Overview

A Multi-Dose Study With a Treatment for Open-Angle Glaucoma

Status:
Withdrawn
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Anecortave Acetate is effective for lowering intraocular pressure caused by open-angle glaucoma.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Alcon Research
Treatments:
Anecortave
Hydrocortisone